Clinical Trials Logo
  1. Home
  2. Out-of-hospital Cardiac Arrest
  3. NCT04921189

Steroid, Thiamine and Ascorbic Acid for Comatose Out-of-hospital Cardiac Arrest Survivors

Out-Of-Hospital Cardiac Arrest Clinical Trial

Official title:
Steroid, Thiamine and Ascorbic Acid During Post-Resuscitation Period for Comatose Out-of-hospital Cardiac Arrest Survivors (STAR) Trial: Multi-center, Randomized, Single-blinded, Controlled Pilot Study

Clinical Trial Summary

The mortality and neurological outcomes among out-of-hospital cardiac arrest survivors have not improved despite the medical advances. The whole body ischemia/reperfusion injuries after cardiac arrest mainly damaged the brain. To improve the neurologic outcome among those patients, additional interventions would be warranted. The investigators hypothesize that the combined use of cortisol, ascorbic acid (vitamin C), and thiamine during the early post-resuscitation period would attenuate the whole-body ischemia/reperfusion injuries among the out-of-hospital cardiac arrest survivors treated with targeted temperature management.

Clinical Trial Description

The mortality and neurological outcomes among the out-of-hospital cardiac arrest survivors are still dismal. In addition, the metabolic and oxidative stress can persist or even worsen at the cellular level after resuscitation, and these whole-body ischemia/reperfusion injuries contribute to multiple organ failure, known as the post-cardiac arrest syndrome. Therefore, additional interventions to reduces the injuries would be warranted. Cortisol has beneficial antioxidant and anti-apoptotic properties and stabilizes cellular membranes exposed to oxidative stress. It also maintains hemodynamic stability and improves organ function by reducing ischemia/reperfusion injuries. Thiamine is a cofactor that acts on enzymes essential for glucose metabolism, the generation of adenosine triphosphate, and nicotinamide adenine dinucleotide phosphate production. It assists the cellular metabolisms and attenuates the potential adverse effect of ascorbic acid (vitamin C) by preventing the conversion of ascorbic acid into oxalate. Ascorbic acid is a well-known antioxidant and has anti-inflammatory effects. It acted as an antioxidant defense substance, reducing reactive oxygen species and reactive nitrogen species and improving microcirculation by limiting oxidative injury and endothelial barrier disruption. The theoretical and experimental studies suggested the concomitant use of cortisol, thiamine, and ascorbic acid might have potential treatment synergism for whole-body ischemia/reperfusion injuries after cardiac arrest. The investigators hypothesize that their combined use during the early post-resuscitation period will reduce the whole-body ischemia/reperfusion injuries, especially the brain, in out-of-hospital cardiac arrest survivors treated with targeted temperature management. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT04921189
Study type Interventional
Source Asan Medical Center
Contact Youn-Jung Kim, PhD
Phone 821030100329
Email yjkim.em@gmail.com
Status Recruiting
Phase Phase 2
Start date December 31, 2021
Completion date December 31, 2023
View Details
See also
  Status Clinical Trial Phase
Recruiting NCT05434910 - Blood Pressure and Cerebral Blood Flow After Cardiac Arrest N/A
Active, not recruiting NCT03700125 - Pre-hospital ECMO in Advanced Resuscitation in Patients With Refractory Cardiac Arrest. ( SUB30 ) N/A
Completed NCT02527694 - CPR Quality Between Flexible Stretcher and Standard Stretcher in OHCA N/A
Completed NCT02899507 - Prophylactic Antibiotics in Comatose Survivors of Out-of-hospital Cardiac Arrest Phase 4
Recruiting NCT02184468 - Survival Study After Out-of-hospital Cardiac Arrest N/A
Completed NCT04085692 - Dispatcher-Assisted CPR: Low-Dose, High-Frequency Simulation-Based Training N/A
Recruiting NCT05029167 - REstrictive Versus LIberal Oxygen Strategy and Its Effect on Pulmonary Hypertension After Out-of-hospital Cardiac Arrest (RELIEPH-study) N/A
Completed NCT04080986 - DOuble SEquential External Defibrillation for Refractory VF N/A
Completed NCT04058925 - Tissue Oxygenation During Cardiopulmonary Resuscitation as a Predictor of Return of Spontaneous Circulation
Enrolling by invitation NCT05113706 - Does Bystanders Emotional State Influence Dispatcher-assisted Cardiopulmonary?Resuscitation
Completed NCT04219306 - Machine Learning Assisted Recognition of Out-of-Hospital Cardiac Arrest During Emergency Calls. N/A
Completed NCT03881865 - P25/30 SSEPs and Neurological Prognosis After Cardiac Arrest
Recruiting NCT04993716 - Epidemiological Study on the Management of Out-of-hospital Cardiac Arrest Survivors in Champagne ArDEnnes
Completed NCT05062785 - Dose-Finding Study of Intranasal Insulin in Healthy Participants Insulin in Healthy Participants Phase 1
Recruiting NCT06122337 - Systemic Evaluation of the Etiologies of Young Adults With Non-traumatic Out-of-hospital Cardiac Arrest
Not yet recruiting NCT04584463 - Factors Associated With CPC 1-2 in 110 Patients Admitted in French ICU for a Myocardial Infarction Complicated by an OHCA.
Recruiting NCT03355885 - Early-onset Pneumonia After Out-of-hospital Cardiac Arrest N/A
Recruiting NCT05132387 - Wroclaw Out-Of-Hospital Cardiac Arrest Registry
Not yet recruiting NCT05969028 - First Responder Airway & Compression Rate Trial N/A
Not yet recruiting NCT06046339 - Left Ventricular Ejection Fraction in Cardiac Arrest Survivors Treated With Extracorporeal Cardiopulmonary Resuscitation